Skip to main content

Table 4 Main results of the ANRS-CUBE intervention study

From: Acceptability of on-site rapid HIV/HBV/HCV testing and HBV vaccination among three at-risk populations in distinct community-healthcare outreach centres: the ANRS-SHS 154 CUBE study

 

Checkpoint

110 Les Halles

El Pasaje Latino

Period of inclusion

1/07/14 30/06/15

16/09/14 22/12/15

01/09/14 21/10/15

Targetted groups

MSM

PWIDs

TGW/SW

Number of users in 2013

4100

550

400

Number of expected participants

2500

110

81

Number of attendances

4042

Missinga

651b

Number of proposals

3718

82 c

517

Number of refusals

56

23

440d

Number of participants tested per protocol

3662

82

77

Acceptability

98.5%

ND

14.9%

Numbers of participants who filled the questionnaire are their first attendance

2945

80

72

Number of new HIV positive participants

44 (1.5%)

4 (4.9%)

0 (0%)

Number of new HBV positive participants

7 (0.19%)

0 (0%)

0 (0%)

Number of new HCV positive participants

3 (0.8%)

5 (6.1%)

0 (0%)

Number of users eligible for HBV vaccination

1682

45

15

Number of HBV vaccination M0 (%)

301 (17.9%)

30 (66.7%)

8 (53.3%)

Number of HBV vaccination M1 (%)

203 (12.1%)

11 (24.4%)

4 (26.7%)

Number of HBV vaccination M6 (%)

97 (5.8%)

3 (6.7%)

0

  1. MSM: men who have sex with men; PWIDs: people who inject drugs; TGW/SW: transgender women/sex workers
  2. aThe total number of attendances for this center was not available
  3. b The number of attendances was recorded on electronic database between 18/02/ and 21/10/2015
  4. c A large number of PWIDs had already been recently tested in anther CAARUD (harm reducing facilities for drug users) or in prison setting
  5. d75% of the TGW/SWs declared being aware of their HIV serological status and HIV screening was not proposed or was refused